Eli Lilly and Co.

Description goes here


Lilly pledges $90 million to improve global drug access

Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
Read More